Canada - English - Health Canada

pharmascience inc - galantamine (galantamine hydrobromide) - tablet - 8mg - galantamine (galantamine hydrobromide) 8mg - parasympathomemetic (cholinergic) agents

Canada - English - Health Canada

pharmascience inc - galantamine (galantamine hydrobromide) - tablet - 12mg - galantamine (galantamine hydrobromide) 12mg - parasympathomemetic (cholinergic) agents

Canada - English - Health Canada

sanis health inc - galantamine (galantamine hydrobromide) - capsule (extended release) - 8mg - galantamine (galantamine hydrobromide) 8mg - parasympathomemetic (cholinergic) agents

Canada - English - Health Canada

sanis health inc - galantamine (galantamine hydrobromide) - capsule (extended release) - 16mg - galantamine (galantamine hydrobromide) 16mg - parasympathomemetic (cholinergic) agents

Canada - English - Health Canada

sanis health inc - galantamine (galantamine hydrobromide) - capsule (extended release) - 24mg - galantamine (galantamine hydrobromide) 24mg - parasympathomemetic (cholinergic) agents

Australia - English - Department of Health (Therapeutic Goods Administration)

southern cross pharma pty ltd - galantamine hydrobromide, quantity: 30.756 mg (equivalent: galantamine, qty 24 mg) - capsule, modified release - excipient ingredients: iron oxide yellow; microcrystalline cellulose; iron oxide red; gelatin; ethylcellulose; hypromellose; magnesium stearate; titanium dioxide; indigo carmine; erythrosine - galantamine is indicated for the treatment of mild to moderately severe dementia of the alzheimer type

Australia - English - Department of Health (Therapeutic Goods Administration)

southern cross pharma pty ltd - galantamine hydrobromide, quantity: 20.504 mg (equivalent: galantamine, qty 16 mg) - capsule, modified release - excipient ingredients: iron oxide red; ethylcellulose; titanium dioxide; hypromellose; gelatin; magnesium stearate; microcrystalline cellulose - galantamine is indicated for the treatment of mild to moderately severe dementia of the alzheimer type

Australia - English - Department of Health (Therapeutic Goods Administration)

southern cross pharma pty ltd - galantamine hydrobromide, quantity: 10.252 mg (equivalent: galantamine, qty 8 mg) - capsule, modified release - excipient ingredients: magnesium stearate; ethylcellulose; titanium dioxide; hypromellose; gelatin; microcrystalline cellulose - galantamine is indicated for the treatment of mild to moderately severe dementia of the alzheimer type

Australia - English - Department of Health (Therapeutic Goods Administration)

southern cross pharma pty ltd - galantamine hydrobromide, quantity: 30.756 mg (equivalent: galantamine, qty 24 mg) - capsule, modified release - excipient ingredients: iron oxide yellow; microcrystalline cellulose; iron oxide red; gelatin; ethylcellulose; hypromellose; magnesium stearate; titanium dioxide; indigo carmine; erythrosine - galantamine is indicated for the treatment of mild to moderately severe dementia of the alzheimer type

Australia - English - Department of Health (Therapeutic Goods Administration)

southern cross pharma pty ltd - galantamine hydrobromide, quantity: 20.504 mg (equivalent: galantamine, qty 16 mg) - capsule, modified release - excipient ingredients: hypromellose; gelatin; ethylcellulose; microcrystalline cellulose; iron oxide red; titanium dioxide; magnesium stearate - galantamine is indicated for the treatment of mild to moderately severe dementia of the alzheimer type